Larry Ramer

Larry Ramer

InvestorPlace Contributor

Larry Ramer has more than 15 years of experience in business journalism. He has worked for Globes, Israel’s most widely read business newspaper, as well as The Jerusalem Post and theflyonthewall.

Mr. Ramer’s expansive knowledge of politics enables him to provide valuable insights into how politics can affect stocks. He also focuses on contrary investing and specializes in the renewable energy and consumer discretionary sectors.

Among his highly successful, contrarian picks have been Super Micro Computer, Intel, and MGM Resorts.

You can reach him on StockTwits at @larryramer and learn more about his stock-picking record at his TipRanks profile.

Recent Articles

With a 3.3 Forward P/E Ratio, Cleveland-Cliffs Is a Great Deal

By Larry Ramer, InvestorPlace Contributor

Stimulus plans in the U.S. and Europe, along with continued strong demand for homes and cars, are a few trends that will boost CLF stock.

Stem Stock Is a Buy on Its Latest Pullback

By Larry Ramer, InvestorPlace Contributor

Stem is set to benefit from very strong macro trends, making STEM stock extremely attractive at this point.

Ocugen Likely Can’t Get a Boost From the FDA Until 2023

By Larry Ramer, InvestorPlace Contributor

It would likely take until mid-2023 for the FDA to approve Covaxin. By that time, the shot could be obsolete. Sell OCGN stock.

GM Stock Is Tremendously Undervalued Amid Strong, Positive Drivers

By Larry Ramer, InvestorPlace Contributor

GM's strong performance in the U.S. and China, along with its improving reputation in the U.S., are among the positive drivers of GM stock.

GameStop Is Still Overvalued Despite More Positive Catalysts

By Larry Ramer, InvestorPlace Contributor

Netflix's entrance into the vide-game sector could help GameStop, but the valuation of GME stock is still far too high.

Load More